These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3880514)

  • 1. The significance of receptor physiology for corticosterone-induced cleft palate in A/J mice.
    Brown KS; Hackman RM
    J Craniofac Genet Dev Biol Suppl; 1985; 1():299-304. PubMed ID: 3880514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of teratogens on maternal corticosterone levels and cleft incidence in A/J mice.
    Sullivan-Jones P; Hansen DK; Sheehan DM; Holson RR
    J Craniofac Genet Dev Biol; 1992; 12(4):183-9. PubMed ID: 1494023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a no-effect dose for corticosteroid-induced cleft palate? The contribution of endogenous corticosterone to the incidence of cleft palate in mice.
    Fawcett LB; Buck SJ; Beckman DA; Brent RL
    Pediatr Res; 1996 May; 39(5):856-61. PubMed ID: 8726241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between maternal restraint and food deprivation, plasma corticosterone, and induction of cleft palate in the offspring of mice.
    Barlow SM; McElhatton PR; Sullivan FM
    Teratology; 1975 Oct; 12(2):97-103. PubMed ID: 1198328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosterone induction of cleft palate in mice dosed with orciprenaline sulfate.
    Iida H; Kast A; Tsunenari Y; Asakura M
    Teratology; 1988 Jul; 38(1):15-27. PubMed ID: 2972086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosterone levels during midgestation in the maternal plasma and fetus of cleft palate-sensitive and -resistant mice.
    Salomon DS; Gift VD; Pratt RM
    Endocrinology; 1979 Jan; 104(1):154-6. PubMed ID: 446342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse.
    Tiboni GM; Marotta F; Del Corso A; Giampietro F
    Toxicol Lett; 2006 Nov; 167(1):8-18. PubMed ID: 16987620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some new aspects of dexamethasone-induced cleft palate in mice.
    Sauerbier I
    Anat Anz; 1987; 163(4):319-22. PubMed ID: 3631525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of maternal plasma corticosterone elevation in the teratogenicity of secalonic acid D in mice.
    Eldeib MM; Reddy CS
    Teratology; 1990 Feb; 41(2):137-46. PubMed ID: 2321159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazepam-induced cleft palate in the mouse: the role of endogenous maternal corticosterone.
    Barlow SM; Knight AF; Sullivan FM
    Teratology; 1980 Apr; 21(2):149-55. PubMed ID: 7394717
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered expression of retinoic acid (RA) receptor mRNAs in the fetal mouse secondary palate by all-trans and 13-cis RAs: implications for RA-induced teratogenesis.
    Naitoh H; Mori C; Nishimura Y; Shiota K
    J Craniofac Genet Dev Biol; 1998; 18(4):202-10. PubMed ID: 10100049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male-mediated teratogenesis: spectrum of congenital malformations in the offspring of A/J male mice treated with ethylnitrosourea.
    Nagao T; Fujikawa K
    Teratog Carcinog Mutagen; 1996; 16(6):301-5. PubMed ID: 9178452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role for corticosterone in the induction of cleft palate in mice after treatment with a selective NK-1 receptor antagonist, casopitant (GW679769B).
    Ziejewski MK; Solomon HM; Stanislaus D; Clark RL; White TE; Apostoli AR
    Birth Defects Res B Dev Reprod Toxicol; 2012 Feb; 95(1):54-62. PubMed ID: 22127931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal changes associated with retinoic acid induced cleft palate in CD-1 mice.
    Degitz SJ; Francis BM; Foley GL
    J Craniofac Genet Dev Biol; 1998; 18(2):88-99. PubMed ID: 9672841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive stages and dose-response analyses of palatal slit and cleft palate in C57BL/6 mice treated with a glucocorticoid.
    Kusanagi T
    Teratology; 1984 Apr; 29(2):281-6. PubMed ID: 6740512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosterone-induced isolated cleft palate in A-J mice.
    Hackman RM; Brown KS
    Teratology; 1972 Dec; 6(3):313-6. PubMed ID: 4643615
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of dose-response relationships to discriminate between the mechanisms of cleft-palate induction by different teratogens: an argument for discussion.
    Biddle FG
    Teratology; 1978 Oct; 18(2):247-52. PubMed ID: 715728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse palatal width growth rates as an "at risk" factor in the development of cleft palate induced by hypervitaminosis A.
    Vergato LA; Doerfler RJ; Mooney MP; Siegel MI
    J Craniofac Genet Dev Biol; 1997; 17(4):204-10. PubMed ID: 9493079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian variation in teratogenic response to dexamethasone in mice.
    Sauerbier I
    Drug Chem Toxicol; 1986; 9(1):25-31. PubMed ID: 3743460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with folic acid and methionine in the prevention of retinoic acid-induced cleft palate in mice.
    Reynolds PR; Schaalje GB; Seegmiller RE
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):168-73. PubMed ID: 12797458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.